Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Journal of Veterinary Science ; : 21-26, 2016.
Article in English | WPRIM | ID: wpr-110769

ABSTRACT

The present study describes the development of DNA vaccines using the hemagglutinin-neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression analysis of the constructs in Vero cells revealed the successful expression of gene inserts in vitro. Moreover, in vivo experiments showed that single vaccination with the constructed plasmid DNA (pDNA) followed by a boost with inactivated vaccine induced a significant difference in enzyme-linked immunosorbent assay antibody levels (p < 0.05) elicited by either pIRES/F, pIRES/F+ pIRES/HN or pIRES-F/HN at one week after the booster in specific pathogen free chickens when compared with the inactivated vaccine alone. Taken together, these results indicated that recombinant pDNA could be used to increase the efficacy of the inactivated vaccine immunization procedure.


Subject(s)
Animals , Antibodies, Viral/blood , Chlorocebus aethiops , Chickens , HN Protein/genetics , Immunogenicity, Vaccine/immunology , Newcastle Disease/immunology , Newcastle disease virus/enzymology , Specific Pathogen-Free Organisms , Vaccines, DNA/genetics , Vaccines, Inactivated/immunology , Vero Cells , Viral Fusion Proteins/genetics , Viral Vaccines/genetics
2.
Yonsei Medical Journal ; : 1149-1157, 2013.
Article in English | WPRIM | ID: wpr-198361

ABSTRACT

PURPOSE: Most chemical transfection reagents are ineffective for the transfection of cells in suspension, such as leukemic cell and stem cell lineages. We developed two different types of viroplexes, cationic Sendai F/HN viroplexes (CSVs) and protamine sulfate-condensed cationic Sendai F/HN viroplexes (PCSVs) for the efficient transfection of T-leukemic cells. MATERIALS AND METHODS: The viroplex systems were prepared by reconstitution of fusogenic Sendai F/HN proteins in DMKE (O,O'-dimyristyl-N-lysyl glutamate) cationic liposomes. The viroplexes were further optimized for plasmid DNA and siRNA delivery to suspension cells. The particle size and surface charge of the viroplexes were analyzed with a zeta-sizer. Transfection of plasmid DNA (pDNA) and small interfering RNA (siRNA) by CSVs or PCSV was evaluated by measurement of transgene expression, confocal microscopy, FACS, and RT-PCR. RESULTS: The optimized CSVs and PCSVs exhibited enhanced gene and siRNA delivery in the tested suspension cell lines (Jurkat cells and CEM cells), compared with conventional cationic liposomes. In the case of pDNA transfection, the CSVs and PCSVs show at least 10-fold and 100-fold higher transgene expression compared with DMKE lipoplexes (or lipofectamine 2000), respectively. The CSVs showed more effective siRNA delivery to the suspension cells than cationic liposomes, as assessed by confocal microscopy, FACS, and RT-PCR. The effective transfection by the CSVs and PCSVs is presumably due to fusogenic activity of F/HN proteins resulting in facilitated internalization of pDNA and siRNA. CONCLUSION: This study suggests that Sendai F/HN viroplexes can be widely applicable for the transfection of pDNA and siRNA to suspension cell lines.


Subject(s)
Humans , Cell Line, Tumor , HN Protein/genetics , Jurkat Cells , RNA, Small Interfering , Sendai virus/genetics , Transfection/methods , Viral Fusion Proteins/genetics , Virosomes
3.
Journal of Veterinary Science ; : 205-211, 2010.
Article in English | WPRIM | ID: wpr-79618

ABSTRACT

Newcastle disease (ND) caused by virulent Newcastle disease virus (NDV) is a highly contagious viral disease of poultry. Virulent NDVs characteristically have a multibasic amino acid sequence (virulence motif) such as (112)RRQKRF(117) at the cleavage site of the precusor fusion (F0) protein. The antigenic and immunogenic characteristics of the virulence motif (112)RRQKRF(117) in the F0 protein of virulent NDVs were investigated. Epitope mapping analysis revealed that a RRQKRF-specific monoclonal antibody 4G2 recognized the KRF section of the motif. A synthetic peptide bearing the RRQKRF motif reacted strongly with sera from virulent NDV (with RRQKRF motif)-infected chickens. These sera also showed reactivity to peptides bearing other virulence motifs ((112)KRQKRF(117), (112)RRQRRF(117) and (112)RRRKRF(117)) but not an avirulence motif ((112)GRQGRL(117)) by ELISA. The synthetic bearing RRQKRF motif reacted with 60% to 91% of sera taken from surviving chickens on ND outbreak farms but not with sera from vaccinated birds, even though most of the sera had antibody to NDV due to vaccination. This indicates that the virulence motif has the potential to differentiate virulent NDV infected birds from vaccinated birds.


Subject(s)
Animals , Amino Acid Motifs/immunology , Amino Acid Sequence , Chickens , Enzyme-Linked Immunosorbent Assay/veterinary , Epitope Mapping/veterinary , Newcastle Disease/immunology , Newcastle disease virus/genetics , Poultry Diseases/immunology , Serologic Tests/veterinary , Viral Fusion Proteins/genetics , Virulence/genetics
4.
Braz. j. med. biol. res ; 26(6): 591-603, Jun. 1993. ilus
Article in English | LILACS | ID: lil-148711

ABSTRACT

1. cDNA recombinants containing the VP3 and VP1 sequences of foot-and-mouth disease virus were isolated and the VP3-VP1 sequence was reconstructed. 2. The reconstructed VP3-VP1 sequence was subcloned into expression vector pEX31b and a fusion protein of about 62,000 Da was expressed. 3. When injected into mice, the fusion protein was able to elicit the production of antibodies that recognized viral VP1 and VP3. 4. Antibodies present in sera from mice immunized with VP3-VP1 protein did not neutralize the foot-and-mouth disease virus in vitro


Subject(s)
Animals , Mice , Antibodies, Viral/biosynthesis , Aphthovirus/genetics , Escherichia coli/genetics , Viral Fusion Proteins/isolation & purification , Aphthovirus/immunology , Blotting, Western , Capsid/genetics , Capsid/immunology , Capsid/isolation & purification , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Neutralization Tests , Viral Fusion Proteins/genetics , Viral Fusion Proteins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL